Also in February we welcome a new start-up at the IZB: Origin.Bio. Jens Klein returns to the site as a serial entrepreneur. A warm welcome!
Below you will find insights into our exciting world of biotechnology.
On March 23, 2022, the Biotech Press Lounge will take place as a hybrid event from the International Press Club in Munich. The topic: the innovations in medicine that move the world! We look forward to your participation - on site or streaming.
With best regards Your Dr. Peter Hanns Zobel Managing Director IZB
Origin.Bio
New Start-up at IZB The company uses bioscience to sustainably produce raw material alternatives on an industrial scale. Read more...
AMSilk
Benoit Cugnet appointed Head of Fiber BU at AMSilk
The International marketing and sales expert will drive the future strategic development of the unit as well as the implementation of its operative growth projects.
Denali Therapeutics exercises option for Secarna Pharmaceuticals’ development program The collaboration offers great potential to develop new therapies for neurodegenerative diseases.
Study indicates that AMSilk engineered silk implant coatings can prevent infection Repellence properties of silk coatings reduced microbial adherence up to 99.7% in comparison to uncoated silicone surfaces. Read more...
münchenTV
A research location with global significance One of the most important sites for the development of drugs and therapies is located just outside Munich. Read more...
EVENTS
Biotech Press Lounge
Hybrid-Event: März 23,2022 This time, the event will take place as a hyprid event at the international Press Club in Munich. Read more...
CAMPUS
MPI Biochemie
Prof. Dr. Danny Nedialkova is EMBO Joung Investigator She will receive four years of access to funding and mentoring and training programs. Read more...
LMU
Study to COVID-19 Three contacts with spike protein triggers broad immune response. Scientists from LMU, Helmholtz Munich, and TUM have shown that the immune system is thus capable of neutralizing even Omicron.
Fit for emergencies IZB and BioNTech SE team attend first aid course together. There are many small details to pay attention to – a refresher course is definitely a very sensible investment.
